Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Diana E Garcia-Camarillo"'
Autor:
Diana E Garcia-Camarillo, David Gómez-Almaguer, Leslie Jazmín López-Silva, César Homero Gutiérrez-Aguirre, Andrés Gómez-De León, Perla R. Colunga-Pedraza, Rosario Salazar-Riojas, Olga G. Cantú-Rodríguez, Mónica Bustillos-Muñoz
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S196-S197
Introduction In the era of haploidentical (haplo) transplantation (alloHSCT) donor availability has been greatly improved and is no longer the biggest barrier for grafting. This fact is particularly important in low and middle-income countries, (LMIC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15cfc7d9baa0eda4f2d59ef988f0c19f
https://doi.org/10.1016/j.bbmt.2019.12.685
https://doi.org/10.1016/j.bbmt.2019.12.685
Autor:
Diana E Garcia-Camarillo, Cesar Homero Gutierrez Aguirre, Andrés Gómez-De León, Paola Santana-Hernandez, Perla R. Colunga-Pedraza, David Gómez-Almaguer, Olga G. Cantú-Rodríguez
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S171-S172
Introduction Donor lymphocyte infusion (DLI) is a useful therapy for mixed chimerism (MC) and measurable residual disease (MRD) after allogeneic transplantation (HSCT). Multiple DLI products can be obtained through apheresis and cryopreservation, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c30148dba69750c01d6e76b07e13447
https://doi.org/10.1016/j.bbmt.2018.12.312
https://doi.org/10.1016/j.bbmt.2018.12.312
Autor:
David Gómez-Almaguer, Diana E Garcia-Camarillo, Paola Santana-Hernandez, César Homero Gutiérrez-Aguirre, Andrés Gómez-De León, Perla R. Colunga Pedraza, César Cantú, Oscar Marquez
Publikováno v:
Blood. 134:5624-5624
Introduction Cytokine release syndrome (CRS) is a common and potentially severe toxicity associated with haploidentical peripheral blood hematopoietic stem cell transplantation (Haplo-HSCT). CRS is characterized by immune activation and a high level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efbf9d24b77f40e6210cf803ea485402
https://doi.org/10.1182/blood-2019-132088
https://doi.org/10.1182/blood-2019-132088
Autor:
Diana E Garcia-Camarillo, Leslie Silva López, Andrés Gómez-De León, Perla R. Colunga Pedraza, Mónica Bustillos Muñoz, David Gómez-Almaguer, César Homero Gutiérrez-Aguirre, Olga Graciela Cantu Rodriguez, Rosario Salazar Riojas
Publikováno v:
Blood. 134:2057-2057
Introduction: Allogeneic hematopoietic stem cell transplantation (alloHSCT) offers an effective, potentially life saving treatment for a broad range of malignant and nonmalignant hematologic disorders. To some degree, an adequate performance status,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9699e45f8454638a7c61cacd3dfbad53
https://doi.org/10.1182/blood-2019-131627
https://doi.org/10.1182/blood-2019-131627
Autor:
David Gómez-Almaguer, Oscar Marquez-Pinedo, Andrés Gómez-De León, Cesar Homero Gutierrez Aguirre, Paola Santana-Hernandez, Luz del Carmen Tarín Arzaga, Olga Graciela Cantu Rodriguez, Diana E Garcia-Camarillo, César Cantú, Perla R. Colunga Pedraza
Publikováno v:
Blood. 132:1043-1043
Introduction: Pernicious anemia is the leading cause of vitamin B12 deficiency worldwide, caused by an autoimmune reaction against parietal cells in the gastric mucosa leading to B12 absorption impairment. The treatment of pernicious anemia is based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714acb3639799944f00295364d8ea030
https://doi.org/10.1182/blood-2018-99-118611
https://doi.org/10.1182/blood-2018-99-118611
Autor:
Perla R. Colunga Pedraza, Cesar Homero Gutierrez Aguirre, David Gómez-Almaguer, Paola Santana-Hernandez, Olga Graciela Cantu Rodriguez, Roberto I. Vázquez-Garza, Andrés Gómez-De León, Diana E Garcia-Camarillo
Publikováno v:
Blood. 132:4602-4602
Introduction: Donor lymphocyte infusion (DLI) is a useful therapy for mixed chimerism (MC) or measurable residual disease (MRD) after allogeneic hematopoietic cell transplantation (HSCT) in patients with malignancies, while it is less effective for o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4aefa0167082b4f4aa52e20936317a3
https://doi.org/10.1182/blood-2018-99-115420
https://doi.org/10.1182/blood-2018-99-115420